z-logo
open-access-imgOpen Access
Weniger Lungenschaden mit Tofacitinib bei COVID-19-Pneumonie
Author(s) -
Peter Dovjak
Publication year - 2021
Publication title -
pneumonews/pneumonews
Language(s) - German
Resource type - Journals
eISSN - 2199-3866
pISSN - 1865-5467
DOI - 10.1007/s15033-021-2760-6
Subject(s) - tofacitinib , medicine , covid-19 , virology , rheumatoid arthritis , disease , outbreak , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here